Compare BLCO & FBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | FBIN |
|---|---|---|
| Founded | 1853 | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Building Products |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.5B |
| IPO Year | 2022 | 2011 |
| Metric | BLCO | FBIN |
|---|---|---|
| Price | $17.32 | $44.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 11 |
| Target Price | $18.45 | ★ $54.60 |
| AVG Volume (30 Days) | 389.8K | ★ 2.7M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $5,101,000,000.00 | $4,463,200,000.00 |
| Revenue This Year | $8.65 | $2.68 |
| Revenue Next Year | $5.59 | $3.60 |
| P/E Ratio | ★ N/A | $4,453.00 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $13.77 | $32.34 |
| 52 Week High | $18.92 | $64.84 |
| Indicator | BLCO | FBIN |
|---|---|---|
| Relative Strength Index (RSI) | 60.73 | 38.97 |
| Support Level | $16.26 | $44.04 |
| Resistance Level | $17.36 | $45.02 |
| Average True Range (ATR) | 0.43 | 1.71 |
| MACD | 0.03 | -0.68 |
| Stochastic Oscillator | 70.37 | 7.68 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.